Apollo Medical Holdings Inc (NASDAQ:AMEH) has earned an average broker rating score of 2.00 (Buy) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating.
Brokers have set a one year consensus price objective of $25.00 for the company and are predicting that the company will post $0.20 EPS for the current quarter, according to Zacks. Zacks has also assigned Apollo Medical an industry rank of 99 out of 255 based on the ratings given to its competitors.
Several research analysts recently weighed in on the company. Zacks Investment Research upgraded Apollo Medical from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research note on Tuesday, October 8th. ValuEngine lowered Apollo Medical from a “buy” rating to a “hold” rating in a research report on Thursday, November 28th.
In related news, major shareholder Physicians Of Californi Allied acquired 12,100 shares of the stock in a transaction dated Wednesday, November 20th. The stock was acquired at an average cost of $17.77 per share, for a total transaction of $215,017.00. Also, insider Adrian Vazquez sold 84,800 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $20.02, for a total transaction of $1,697,696.00. In the last 90 days, insiders have bought 114,702 shares of company stock worth $2,018,994. Corporate insiders own 11.83% of the company’s stock.
A number of hedge funds have recently modified their holdings of the stock. Rhumbline Advisers purchased a new stake in Apollo Medical during the 3rd quarter valued at about $526,000. Wells Fargo & Company MN raised its stake in shares of Apollo Medical by 23.4% in the second quarter. Wells Fargo & Company MN now owns 32,722 shares of the company’s stock worth $547,000 after purchasing an additional 6,215 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Apollo Medical by 113.7% in the second quarter. JPMorgan Chase & Co. now owns 1,733 shares of the company’s stock worth $28,000 after purchasing an additional 922 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Apollo Medical by 9.6% in the second quarter. Vanguard Group Inc. now owns 1,164,827 shares of the company’s stock worth $19,464,000 after purchasing an additional 102,267 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Apollo Medical by 2.0% during the second quarter. Bank of New York Mellon Corp now owns 61,347 shares of the company’s stock worth $1,025,000 after purchasing an additional 1,205 shares during the period. Institutional investors own 15.96% of the company’s stock.
About Apollo Medical
Apollo Medical Holdings, Inc, a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
See Also: Overbought
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.